Clinical Study

Human Leukocyte Antigen Class I and II Alleles and Overall Survival in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Table 1

Demographic and clinical characteristics of DLBCL and FL patients from the NCI-SEER NHL study for which HLA typing was conducted.

CharacteristicsDLBCLFL
š‘› (%) š‘› (%)

Sex
ā€ƒMale99 (55.3)89 (49.4)
ā€ƒFemale80 (44.7)91 (50.6)
Age (years)
ā€ƒ<6093 (52.0)103 (57.2)
ā€ƒ60+86 (48.0)77 (42.8)
Race
ā€ƒNon-Hispanic Caucasian165 (92.2)165 (91.7)
ā€ƒOther14 (7.8)15 (8.3)
Study Center
ā€ƒDetroit19 (10.6)16 (8.9)
ā€ƒIowa67 (37.4)76 (42.2)
ā€ƒLos Angeles29 (16.2)30 (16.7)
ā€ƒSeattle64 (35.8)58 (32.2)
Education (years)
ā€ƒ<1216 (8.9)11 (6.1)
ā€ƒ12ā€“15118 (65.9)118 (65.6)
ā€ƒ16+45 (25.1)51 (28.3)
Stage
ā€ƒLocal69 (38.6)44 (24.4)
ā€ƒRegional39 (21.8)25 (13.9)
ā€ƒDistant38 (38.0)101 (56.1)
ā€ƒUnknown3 (1.7)10 (5.6)
Presence of B symptoms
ā€ƒNo136 (76.0)154 (85.6)
ā€ƒYes43 (24.0)26 (14.4)